| Filed On | Filing |
|---|---|
| 19 Aug 2021 |
8-K/A: Regulation FD Disclosure
The information under “Explanatory Note” above is incorporated into this Item 7.01 by reference. |
| 05 Nov 2019 |
8-K/A: Results of Operations and Financial Condition
Alignment with FDA on GMP Commercial Manufacturing Process for KB103 (Bercolagene telserpavec, “B-VEC”) |
Loading...